NOTICIAS
- A renewable cell source for cancer immunotherapy could make off-the-shelf treatments possible
- New tool maps how T cells move within tumors
- Lab-on-a-chip platform shows how immune cells attack cancer cells
- A diet-derived nutrient in breast milk may shape immune development
- SARS and MERS trigger immune brake that shuts down antiviral defenses, study finds
- Diabetes and obesity drugs may help with inflammation and repair of skin
- Rewired metabolism helps revive exhausted immune cells and boost cancer immunity
- Immune cell circuit restores barrier function in inflammatory bowel disease
- Mapping immune cell interactions in gut tissue reveals changes in ulcerative colitis
- An intranasal flu vaccine approved two decades ago may have underappreciated immune benefits
- Asthma attacks reshape airway tissue through mechanical stress, lung-on-a-chip reveals
- Genetic cause for rare skin condition points to new therapeutic option
- Target with potential to improve CAR T-cell therapy response in patients with blood cancers identified
- Crohn’s atlas maps gene shifts across more than 50 gut cell types
- Immune activation may determine success of dual-target CAR T therapy in glioblastoma
- Why some immunotherapy fails: Tumor-triggered neutrophils can shut down cancer-killing T cells
PUBLICACIONES
- A renewable cell source for cancer immunotherapy could make off-the-shelf treatments possible
- New tool maps how T cells move within tumors
- Comprehensive characterization of the inflammatory ecosystems in immunotherapy-induced adverse events versus chronic inflammatory diseases
- Activation of tumor-specific CD8+ T cells prior to radiopharmaceutical therapy improves antitumor response
- Neoadjuvant camrelizumab plus chemotherapy in resectable stage IIIA-IIIB non-small cell lung cancer: integrated multidimensional biomarker analysis from a phase II study
- Predicting immune-related thyroiditis using polygenic risk scores in patients with advanced melanoma
- HDAC inhibitors reverse YAP-driven immune resistance in NSCLC: mechanistic and translational evidence
- Advances in immunotherapies in ovarian cancer
- Differential cytokine architecture in patients treated with CART19 versus CART22
- Evaluating the safety of Janus kinase inhibitors in the management of severe immune-related adverse events
- First-in-human study of lomvastomig, a PD-1-TIM-3 bispecific antibody, in patients with advanced and/or metastatic solid tumors
- Tumor cell ferroptosis in antitumor immunity and immunotherapy efficacy
- Programming the immunological properties of mRNA vaccines for cancer
- Correction: Safety of immune checkpoint inhibitors for cancer treatment: real-world retrospective data analysis from Qatar (SAFE-ICI-Q study)
- Ophthalmic involvement in VEXAS syndrome and its influence on mortality: insights from the international AIDA network registry
- Single dose of 5 Gy can damage erythrocytes and consequently induces lymphocyte depletion in spleen and circulating blood
- Contemporary review of primary membranous nephropathy
- The lactylation axis: bridging metabolic reprogramming and immunosuppression in the tumor microenvironment
- Targeting the ISG15+STAT1+ monocyte-driven inflammatory storm with Fedratinib in traumatic lung injury via the JAK2/STAT3/PIM1 axis
- Proteasome inhibition induces a BRCAness-like state and sensitises HR-proficient ovarian cancer models to PARP inhibitors
- Neonatal CD19+B220lo cells sense microbiota via TLR2/4 activation driving proliferation and differentiation
- Circadian control of immune homeostasis in cardiovascular health and disease
- PANoptosis in diabetic retinopathy: immunological insights into mechanisms and translational therapies
- New-onset allergic diseases after SARS-CoV-2 infection: mechanistic hypotheses and emerging strategies for risk stratification
- Extracellular vesicles as new-age vaccine carriers: a focused account on viral diseases
- AF6 orchestrates macrophage polarization via JAK2-STAT3 signaling and supports intestinal regeneration by stimulating stem cell proliferation
- A self-perpetuating neuron-intrinsic GSDMD–mtDNA–AIM2 inflammasome axis drives neuronal pyroptosis and cognitive impairment after traumatic brain injury
- Mechanistic constraints in dengue severity: a systematic review with evidence stratification and agent-based evaluation of logical sufficiency
- FcRn antagonist and C5 complement inhibitor as early rescue strategies in severe Myasthenia Gravis: a two-case report
- Transplacental transfer of anti-malarial antibodies: a systematic review
- Restoring immune homeostasis in the spinal microenvironment: targeting mechano-inflammation and immunometabolic reprogramming
- Neural regulation of tumor progression: implications for hepatocellular carcinoma